Docoh
Loading...

ABT Abbott Laboratories

News

From Benzinga Pro
10 Health Care Stocks With Whale Alerts In Today's Session
27 Jan 22
Options
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
What 5 Analyst Ratings Have To Say About Abbott Laboratories
27 Jan 22
Analyst Ratings
Over the past 3 months, 5 analysts have published their opinion on Abbott Laboratories (NYSE:ABT) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
Morgan Stanley Maintains Overweight on Abbott Laboratories, Lowers Price Target to $151
27 Jan 22
News, Price Target, Analyst Ratings
Morgan Stanley maintains Abbott Laboratories (NYSE:ABT) with a Overweight and lowers the price target from $157 to $151.
Raymond James Maintains Outperform on Abbott Laboratories, Lowers Price Target to $143
27 Jan 22
News, Price Target, Analyst Ratings
Raymond James analyst Jayson Bedford maintains Abbott Laboratories (NYSE:ABT) with a Outperform and lowers the price target from $150 to $143.
Abbott Laboratories Whale Trades For January 26
26 Jan 22
Options, Markets
Someone with a lot of money to spend has taken a bullish stance on Abbott Laboratories (NYSE:ABT). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Abbott Posts $2.3B In COVID-19 Test Sales In Q4; Issues FY22 Outlook
26 Jan 22
Earnings, News, Guidance, Health Care, General
Abbott Laboratories (NYSE: ABT) has reported
The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data
26 Jan 22
Biotech, Earnings, News, Penny Stocks, Offerings, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
Recap: Abbott Laboratories Q4 Earnings
26 Jan 22
Earnings, News
Abbott Laboratories (NYSE:ABT) reported its Q4 earnings results on Wednesday, January 26, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Abbott Laboratories Q4 EPS $1.32 Beats $1.21 Estimate, Sales $11.50B Beat $10.71B Estimate
26 Jan 22
Earnings, News
Abbott Laboratories (NYSE:ABT) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.21 by 9.09 percent. This is a 8.97 percent decrease over earnings of $1.45 per share from the
A Peek Into The Markets: US Stock Futures Gain; Fed Policy Decision In Focus
26 Jan 22
Earnings, News, Eurozone, Futures, Global, Pre-Market Outlook, Markets
Pre-open movers
7 Stocks To Watch For January 26, 2022
26 Jan 22
Earnings, News, Pre-Market Outlook, Markets, Trading Ideas
Some of the stocks that may grab investor focus today are: Wall Street expects AT&T Inc. (NYSE: T) to report quarterly earnings at $0.76 per share on revenue of $40.43 billion before the opening bell. AT&T shares fell 0.2% to $26.42 in after-hours trading.
Earnings Scheduled For January 26, 2022
26 Jan 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Blue Foundry (NASDAQ:BLFY) is projected to report earnings for its fourth quarter.
A Preview Of Abbott Laboratories's Earnings
25 Jan 22
Earnings
Abbott Laboratories (NYSE:ABT) is set to give its latest quarterly earnings report on Wednesday, 2022-01-26. Here's what investors need to know before the announcement. Analysts estimate that Abbott Laboratories will likely report an Earnings Per Share (EPS) of $1.20.
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
23 Jan 22
Biotech, Earnings, News, FDA, IPOs, Top Stories, General
Biotech stocks pulled back yet again during the week ending Jan. 21, with the sector retreating along with the broader market. The news flow tapered off following the frenetic pace of the week that encompassed the JPM Healthcare conference.
Price Over Earnings Overview: Abbott Laboratories
21 Jan 22
Earnings, News, Intraday Update, Markets
CNBC's Final Trades: Abbott Laboratories, Starbucks, Bank of America And This Financial Services Stock
21 Jan 22
Long Ideas, Media, Trading Ideas
On CNBC’s “Halftime Report Final Trades,” Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories (NYSE: ABT) as her pick.
Government Website For Free At-Home COVID Test Kit Opens Ahead Of Schedule: How To Get Yours
18 Jan 22
Government, News, Health Care, General
The U.S. government was set to officially open a website for Americans to order free COVID-19 rapid test kits on Wednesday, Jan. 19, but the site has begun taking names and addresses one day early.
FDA Clears Abbott's Latest EnSite Heart Mapping Platform
12 Jan 22
News, Health Care, FDA, General
Abbott Laboratories (NYSE: ABT) has
Abbott Receives FDA Clearance For New Cardiac Mapping System
12 Jan 22
Biotech, News, FDA, General
ABBOTT PARK, Ill., Jan. 12, 2022 /PRNewswire/ -- Abbott (NYSE:ABT) today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar
'FDA Acting Commissioner Woodcock on rapid tests. There are now total of 15 authorized by FDA. New program in place to accelerate review of these tests.' -News Nation Reporter
11 Jan 22
News, FDA
https://twitter.com/EvanLambertTV/status/1480927544518094860

Press releases

From Benzinga Pro
Abbott Reports Strong Fourth-Quarter 2021 Results; Issues 2022 Forecast
26 Jan 22
Earnings, Dividends, Press Releases
ABBOTT PARK, Ill., Jan. 26, 2022 /PRNewswire/ -- Abbott (NYSE:ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook for 2022. Fourth-quarter
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
12 Jan 22
Press Releases
ABBOTT PARK, Ill., Jan. 12, 2022 /PRNewswire/ -- Abbott (NYSE:ABT) today announced it has received clearance from the U.S. Food and Drug Administration for the EnSite™ X EP System with EnSite Omnipolar Technology
ACELYRIN Appoints Melanie Gloria as Chief Operating Officer
11 Jan 22
Press Releases
LOS ANGELES, Jan. 11, 2022 /PRNewswire/ -- ACELYRIN, INC., a biopharma company focused on providing patients life-changing new treatment options by identifying, acquiring, and accelerating development and
Abbott Announces Future of Biowearables at Consumer Electronics Show
6 Jan 22
Press Releases
LAS VEGAS, Jan. 6, 2022 /PRNewswire/ -- Making CES history, Abbott (NYSE:ABT) presented a keynote at the most influential tech event in the world, the first healthcare company ever to do so. Abbott Chairman and Chief
Abbott Hosts Conference Call for Fourth-Quarter Earnings
4 Jan 22
Press Releases
ABBOTT PARK, Ill., Jan. 4, 2022 /PRNewswire/ -- Abbott (NYSE:ABT) will announce its fourth-quarter 2021 financial results on Wednesday, Jan. 26, 2022, before the market opens. The announcement will be followed by a
Abbott's Proclaim™ XR Spinal Cord Stimulation System Now Offers Expanded MRI Compatibility in U.S.
4 Jan 22
Press Releases
ABBOTT PARK, Ill., Jan. 4, 2022 /PRNewswire/ -- Abbott (NYSE:ABT) announced today that the U.S. Food and Drug Administration (FDA) has approved new expanded magnetic resonance imaging (MRI) compatibility for its
Biosion, Inc. Appoints Anthony Yeh, Ph.D., as Chief Strategy Officer and Head of China BD
3 Jan 22
Press Releases
NEWARK, Del. and NANJING, China, Jan. 3, 2022 /PRNewswire/ -- Biosion, Inc. ("Biosion"), a global clinical stage biotechnology company, today announced the appointment of Dr. Anthony Yeh to the position of Chief
Abbott to Present at J.P. Morgan Healthcare Conference
21 Dec 21
Press Releases
ABBOTT PARK, Ill., Dec. 21, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 11, 2022. Robert B. Ford, chairman and chief executive
Abbott Names Robert B. Ford Chairman of the Board; Miles D. White to Retire as Executive Chairman
10 Dec 21
Press Releases
ABBOTT PARK, Ill., Dec. 10, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) announced that its Board of Directors has elected Chief Executive Officer Robert B. Ford as Chairman of the Board, effective today. Miles D. White,
Abbott Increases Quarterly Dividend for 50th Consecutive Year
10 Dec 21
Dividends, Press Releases
ABBOTT PARK, Ill., Dec. 10, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) today announced that its board of directors has increased the company's quarterly common dividend, marking the company's 50th consecutive year of
Abbott Launches Similac® 360 Total Care® with Exclusive Blend of Five HMO Prebiotics and Designed to Support the Immune System, Digestive Health and Brain Development
16 Nov 21
Press Releases
ABBOTT PARK, Ill., Nov. 16, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) today announced the launch of Similac 360 Total Care, the company's next generation of infant formula with HMOs, major prebiotics structurally
Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
15 Nov 21
Press Releases
ABBOTT PARK, Ill., Nov. 15, 2021 /PRNewswire/ -- On Nov. 12, Abbott (NYSE:ABT) achieved the highest score out of 84 companies in its industry in the S&P Global Corporate Sustainability Assessment, also called the Dow
Abbott's New Leadless Pacemaker System Meets Primary Endpoints in Pivotal Trial
12 Nov 21
Press Releases
ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless pacemaker in
Covid-19 Test Shortage Emphasized by New $70M Plan to Speed Up Authorizations
9 Nov 21
Small Cap, Opinion, Press Releases
VANCOUVER, B.C., Nov. 9, 2021 /PRNewswire/ -- USA News Group - New at-home Covid tests are on the way, according to the Biden administration, which announced a new $70 million plan to speed up authorization, especially
Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology
9 Nov 21
Press Releases
ABBOTT PARK, Ill. and ARLINGTON, Va., Nov. 9, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) and the American Diabetes Association® (ADA) announced today the launch of their first joint community health partnership. The
Atrial Fibrillation Market Is Expected To Reach $11.123 Billion At A CAGR 11.2 % Through 2023
4 Nov 21
Opinion, Press Releases
PALM BEACH, Fla., Nov. 4, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Atrial fibrillation is an ailment in which the heart beats irregularly, unlike the usual heartbeat. The upper chambers of the heart,
Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations
3 Nov 21
Press Releases
ABBOTT PARK, Ill., Nov. 3, 2021 /PRNewswire/ -- Abbott (NYSE:ABT) today announced the launch of a new initiative designed to help create a more inclusive clinical trial ecosystem through new approaches to training,